Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets
- 1 March 1986
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 35 (5), 787-800
- https://doi.org/10.1016/0006-2952(86)90247-9
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Inhibition of a high affinity cyclic AMP phosphodiesterase and relaxation of canine tracheal smooth muscleBiochemical Pharmacology, 1982
- Selective inhibition of separated forms of cyclic nucleotide phosphodiesterase from rat heart by some cardio- or vaso-active butenolide derivativesBiochemical Pharmacology, 1982
- Characterization of Two Forms of Cyclic Nucelotide Phosphodiesterase from Rabbit HeartPublished by Springer Nature ,1982
- On the Mechanism of Relaxation of Tracheal Muscle by Theophylline and Other Cyclic Nucleotide Phosphodiesterase InhibitorsActa Pharmacologica et Toxicologica, 1979
- Human blood platelet 3′:5′-cyclic nucleotide phosphodiesterase: Isolation ofBiochimica et Biophysica Acta (BBA) - Enzymology, 1976
- Cyclic nucleotide phosphodiesterase activities of pig coronary arteriesBiochimica et Biophysica Acta (BBA) - Enzymology, 1975
- The role of cyclic GMP in the regulation of cyclic AMP hydrolysisMetabolism, 1975
- Studies with phophodiesterase. III. Two forms of the enzyme from human blood plateletsBiochimica et Biophysica Acta (BBA) - Enzymology, 1973
- Separate Phosphodiesterases for the Hydrolysis of Cyclic Adenosine 3′,5′-Monophosphate and Cyclic Guanosine 3′,5′-Monophosphate in Rat LiverPublished by Elsevier ,1973
- Membrane formation in Tetrahymena pyriformis. 4. Lipid composition and biochemical properties of Tetrahymena pyriformis membrane systemsBiochemistry, 1971